We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology
PeriodicalsMedical Sciences

The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology

Checking your access to this record.

Abstract & Overview

No abstract is available for this record.

Cite this record

Elna M. Masuda, Kathleen J. Ozsvath, John D. Vossler, Karen Woo, Robert L. Kistner, Fedor Lurie, et al. (2020). The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. Journal of Vascular Surgery Venous and Lymphatic Disorders, 8(4), 505–525.e4. https://doi.org/10.1016/j.jvsv.2020.02.001

Copy in another style

Masuda, E. M., Ozsvath, K. J., Vossler, J. D., Woo, K., Kistner, R. L., Lurie, F., Monahan, D., Brown, W., Labropoulos, N., & Dalsing, M. C. (2020). The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. Journal of Vascular Surgery Venous and Lymphatic Disorders, 8(4), 505–525.e4. https://doi.org/10.1016/j.jvsv.2020.02.001
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.